Accelus announced that it entered into a definitive business combination agreement with CHP Merger Corp. worth approximately $482 million. Upon the closing of the agreement — expected for early 2022 — CHP Merger Corp., a special purpose acquisition company (SPAC), will be renamed Accelus. Accelus co-founder and CEO Chris Walsh, formerly of Stryker and NuVasive, […]